Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Anaplastic large-cell lymphoma
ADR ID BADD_A06726
ADR Hierarchy
01      Blood and lymphatic system disorders
01.12      Lymphomas NEC
01.12.01      Lymphomas unspecified NEC
01.12.01.003      Anaplastic large-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.20      Lymphomas NEC
16.20.01      Lymphomas unspecified NEC
16.20.01.003      Anaplastic large-cell lymphoma
Description A systemic, large-cell, non-Hodgkin, malignant lymphoma characterized by cells with pleomorphic appearance and expressing the CD30 ANTIGEN. These so-called "hallmark" cells have lobulated and indented nuclei. This lymphoma is often mistaken for metastatic carcinoma and MALIGNANT HISTIOCYTOSIS. [MeSH]
MedDRA Code 10073478
MeSH ID D017728
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anaplastic large-cell lymphoma | Lymphoma, Large-Cell, Anaplastic | CD30-Positive Anaplastic Large-Cell Lymphoma | CD30 Positive Anaplastic Large Cell Lymphoma | Systemic Anaplastic Large-Cell Lymphoma | Systemic Anaplastic Large Cell Lymphoma | Lymphoma, Large-Cell, Ki-1 | Anaplastic Large-Cell Lymphoma | Anaplastic Large Cell Lymphoma | Anaplastic Large-Cell Lymphomas | Large-Cell Lymphoma, Anaplastic | Large-Cell Lymphomas, Anaplastic | Lymphoma, Anaplastic Large-Cell | Lymphomas, Anaplastic Large-Cell | CD30+ Anaplastic Large-Cell Lymphoma | CD30+ Anaplastic Large Cell Lymphoma | Ki-1 Lymphoma | Ki 1 Lymphoma | Ki-1 Lymphomas | Lymphoma, Ki-1 | Lymphomas, Ki-1
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01352Maraviroc--
BADD_D01418Methotrexate--
BADD_D02383Zidovudine0.006631%
The 1th Page    1    Total 1 Pages